“A Review on the Therapeutic Targeting of the Gut Microbiome for the Mitigation of Type 2 Diabetes Mellitus: Review article” (2026) Journal of Pharma Insights and Research, 4(3), pp. 099–116. doi:10.69613/7rzc7r52.